Related Experiment Video
Updated: May 17, 2026

Scanning Skeletal Remains for Bone Mineral Density in Forensic Contexts
Published on: January 29, 2018
Bone health in children with long-term idiopathic subclinical hypothyroidism
Raffaella Di Mase1, Manuela Cerbone, Nicola Improda
1Department of Pediatrics, University of Naples, Federico II, Naples, Italy.
Insights
Subclinical hypothyroidism (SH) in children does not impair bone health, as assessed by dual-energy X-ray densitometry (DXA) and quantitative ultrasound (QUS). Quantitative ultrasound (QUS) is a safe and cost-effective screening tool for bone evaluation in pediatric SH.
Area of Science:
- Pediatric Endocrinology
- Bone Metabolism
- Thyroid Disorders
Background:
- Subclinical hypothyroidism (SH) is a common condition of mild thyroid failure.
- Management of pediatric SH and L-thyroxine treatment decisions remain controversial.
- Thyroid hormone and TSH are crucial for skeletal growth and bone mineral homeostasis.
Purpose of the Study:
- To assess the impact of untreated idiopathic SH on childhood bone health.
- To compare dual-energy X-ray densitometry (DXA) and quantitative ultrasound (QUS) for bone assessment in children with SH.
Main Methods:
- Twenty-five children with untreated idiopathic SH and 25 age/sex-matched controls were studied.
- SH diagnosis: normal FT4 with TSH 4.2-10 mU/l.
- Bone assessment using DXA (lumbar spine BMD) and QUS (phalangeal Ad-SoS, BTT) over 3.3 years.
Main Results:
- No statistically significant differences in bone mineral density (BMD) Z-scores between SH patients and controls.
- No significant differences in quantitative ultrasound (QUS) parameters (Ad-SoS, BTT) Z-scores.
- All bone health parameters were within normal ranges for both groups.
Conclusions:
- Long-term idiopathic SH does not appear to impair bone health in children, based on DXA and QUS findings.
- QUS provides comparable bone status data to DXA in this pediatric cohort.
- QUS is a suitable, cost-effective, and safe screening tool for bone evaluation in children with SH.
Background:
Subclinical hypothyroidism (SH) is a relatively common condition characterized by a mild persistent thyroid failure. The management of children with SH is still a controversial issue and the decision to treat with L-thyroxine represents a clinical dilemma. Thyroid hormone and TSH play an important role in skeletal growth and bone mineral homeostasis.
Aim:
To evaluate whether untreated idiopathic SH may affect bone health in childhood and to compare two different diagnostic tools such as dual-energy X-ray densitometry (DXA) and quantitative ultrasound (QUS).
Patients And Methods:
Twenty-five children and adolescents (11 males) aged 9.8 ± 3.5 years (range 4.2-18.7) with untreated idiopathic SH were enrolled in the study. SH was diagnosed on the basis of normal FT4 levels with TSH concentrations between 4.2 and 10 mU/l. Children have been followed for 3.3 ± 0.3 years from the time of SH diagnosis. Twenty-five healthy children, age- and sex-matched, were enrolled as controls. Patients and controls underwent DXA to evaluate lumbar spine bone mineral density (BMD) and QUS at proximal phalanges of the non-dominant hand to assess bone quality, measured as amplitude-dependent speed of sound (Ad-SoS) and bone transmission time (BTT).
Results:
Mean BMD Z-score was -0.4 ± 1.36 in patients and -0.2 ± 1.2 in controls. Mean Ad-SoS Z-score was 0.01 ± 1.0 in patients and 0.1 ± 1.2 in controls and mean BTT Z-score was -0.03 ± 0.8 and 0.04 ± 1.1 respectively. All values were within the normal range, both in patients and in controls. There were no statistically significant differences between the two groups.
Conclusion:
Bone health, evaluated by lumbar spine DXA and phalangeal QUS, is not impaired in our children, despite long-term duration of idiopathic SH. Data about bone status provided by QUS are comparable to those provided by DXA. Therefore, QUS may represent a good, cheaper and safe screening test for bone evaluation in children with SH.
More Related Videos
Related Concept Videos
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hypothyroidism II: Pathophysiology
Functions of Thyroid Hormones
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
Hyperthyroidism II: Pathophysiology
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...

